In this Syndicated Report focusing on CAR-T therapy, and new and emerging trends in Cancer Treatment, we had two main objectives:
- To understand the knowledge and excitement level for emerging trends in cancer treatment, specifically with chimeric antigen receptor T cell (CAR-T) therapy
- To understand the drivers of use and future expectations for autologous vs. allogeneic CAR-T
Interview Exploration: n=3 30-minute interviews with Hematologists profiled as “thought leaders” in new cancer treatments to share experience and hypotheses prior to survey
Methodology: 3-Minute MicroSurvey
Crowds: US Hematologists, US Oncologists
Fielding Period: August 13-15, 2019
Download the report now!